FDA 483 - Lonza AG (Standort Sterilprodktion Stein)

Lonza AG in Stein, Switzerland, was inspected by the FDA, resulting in one observation. The inspection found that equipment components used in a drug product filling line were not sterilized prior to use, indicating a potential risk to product quality and patient safety. This suggests a significant lapse in aseptic processing controls.